In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, Eris Lifesciences has informed that it enclosed schedule of Analyst/ Institutional Investor Meeting held on Thursday, 10th June, 2021.
The above information is a part of company’s filings submitted to BSE.